Early identification and diagnosis of sepsis and septic shock is vitally important; despite
appropriate management, mortality and morbidity rates remain high. For this reason, many …

Sepsis and septic shock represent a leading cause of mortality in the Emergency
Department (ED) and in the Intensive Care Unit (ICU). For these life-threating conditions …

Mid-regional pro-adrenomedullin (MR-proADM) has a good biomarker profile: its half-life is
several hours, and its plasma concentrations can be determined in clinical practice, it is …

Abstract Background Midregional proadrenomedullin (MR-proADM) is a prognostic
biomarker in patients with community-acquired pneumonia (CAP) and sepsis. In this paper …

Sepsis causes immune dysregulation and endotheliitis, with an increase in mid-regional pro-
adrenomedullin (MR-proADM). The aim of the study is to determine an MR-proADM value …

PRINCIPLES: Midregional proadrenomedullin (proADM) is a novel biomarker with potential
prognostic utility in patients with community-acquired pneumonia. The aim of this study was …

Background This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …

Background The use of novel sepsis biomarkers has increased in recent years. However,
their prognostic value with respect to illness severity has not been explored. In this work, we …

Background Mortality risk and outcome in critically ill patients can be predicted by scoring
systems, such as APACHE and SAPS. The identification of prognostic biomarkers, simple to …

Background Mid-regional proadrenomedullin (MR-proADM) is a novel biomarker with
potential prognostic utility in patients with community-acquired pneumonia (CAP). Purpose …